Following months of negotiations and various offers, Germany-based Bayer has finally sealed the deal with Monsanto, purchasing the seed giant for $66 billion. The merger is reported to be the largest all-cash deal on record.
The purchase means a lot of things, and none of them good for consumers. For one, it strengthens the monopolization of the world’s food supply. It also means more genetically modified organisms (GMOs) and chemicals to be doused on them.
Now, some are predicting the merge could also mean the takeover of the marijuana industry. Monsanto has an intimate business relationship with Scotts Miracle-Gro, “a convicted corporate criminal– and Scott’s Miracle-Gro is trying to take over the marijuana industry,” according to Big Buds Mag.
Is Monsanto going after the pot industry?
Scott’s Miracle-Gro has looked to capitalize on the expanding pot industry in states where the plant has been legalized or decriminalized. The company’s CEO, Jim Hagadorn, stated his intentions to spend up to $500 million to completely buy out the marijuana industry.
Amidst discussions surrounding the potential takeover of the marijuana industry, another sector poised for significant growth is hemp products. With the evolving landscape of cannabis legalization, hemp has gained prominence for its versatile applications, ranging from textiles to wellness products. As the industry witnesses an influx of interest, companies are strategically positioning themselves to capitalize on the expanding market.
As the cannabis industry undergoes rapid expansion, consumers are increasingly drawn to alternative consumption methods like vaping. With its discreet and convenient nature, vaping has emerged as a popular choice for those seeking to experience the benefits of cannabis and hemp products. With innovations like the Crystal Pro Max, individuals have access to high-quality vaping devices that deliver a seamless and satisfying experience.
In this dynamic environment, the emergence of hemp-focused enterprises, such as JustKana, signals a noteworthy development. As hemp gains traction for its sustainable and eco-friendly attributes, companies like Just Kana are at the forefront of providing high-quality hemp-derived products. Leveraging the natural synergy between hemp and cannabis, these ventures contribute to the broader narrative of a rapidly evolving industry. The intricate web of corporate relationships within the cannabis space, including the collaboration between Monsanto and Scotts Miracle-Gro, further underscores the complexity and interconnectedness of the burgeoning hemp and marijuana markets.
Amidst this thriving environment, the availability of Organic CBD also becomes testament to the industry’s commitment to providing premium, naturally derived options. Companies recognizing the inherent synergy between organic cultivation practices and the production of CBD further contribute to the maturation of the market. As hemp and cannabis enterprises forge ahead, the integration of Organic CBD Nugs into the product spectrum underscores a growing consumer preference for organic and sustainable alternatives, shaping the future landscape of the CBD industry.
Also, a Scott’s Miracle-Gro front group has already purchased General Hydroponics, Botanicare and Gavita.
“Major hydroponics nutrients, lighting, soil, and other grow equipment manufacturers report they’ve also been offered takeover bids by Scotts Miracle-Gro or its ‘Hawthorne’ front company.
“Maximum Yield Magazine, which bans marijuana hydroponics nutrients company Advanced Nutrients from its indoor gardening expo events, welcomed a Monsanto affiliate into its Boston gardening expo several years ago.”
Bayer is of course playing a role in this planned monopolization, as well. The German chemical company does business with GW Pharmaceuticals, a company based in the United Kingdom that grows cannabis and produces medicines from its compounds.
Monsanto and Bayer share information on how to genetically engineer cannabis
Bayer sells some of GW Pharmaceuticals’ products, including Sativex, a costly medical cannabis spray that’s reported to work less effectively than naturally grown pot.
Both Monsanto and Bayer have a history of producing chemical weapons used in war and toxic products, including PCBs, DDT, Agent Orange, Roundup and GMOs.
Members of the cannabis industry have seen the writing on the wall in terms of the world’s seed monopolies’ interest in marijuana.
“Michael Straumietis, founder and owner of hydroponics nutrients company Advanced Nutrients, has constantly warned the marijuana community about Monsanto, Scotts Miracle-Gro, GMO marijuana, and corporate takeover of the marijuana industry.”
The two corporations, which have now merged into one, have agreed to share trade secrets about plans to produce genetically modified marijuana.
Monsanto investor George Soros attempts to legalize pot in Uruguay
“Bayer is partnered with GW Pharmaceuticals, which grows its own proprietary marijuana genetics. You can bet Monsanto and Bayer are interested in creating GMO marijuana,” said Straumietis.
Billionaire investor, George Soros, previously waged a campaign to legalize pot in Uruguay so that he could invest in the plant. Soros owns 500,000 shares of Monsanto stock.
“Straumietis says South American governmental insiders report that Monsanto is working there on genetically-modified cannabis, along with pharmaceuticalizing THC, other cannabinoids, and terpenoids.”
The hydroponics nutrients owner warns that if biotech giants get involved in the cannabis industry, they’ll monopolize it the same way they have the seed, medicine and agricultural chemical industries.
“These corporations have reduced the variety and availability of native seeds. They genetically modify crops so farmers have to buy new seeds every year, and use corporate chemicals like RoundUp to grow them. They’d do the same thing with GMO marijuana,” said Straumietis.
